Skip to Main Content
Table 1

Characteristics of all participants of the EURODIAB PCS and those who were included in the Nerve Conduction substudy analysis

EURODIAB follow-upNerve conduction tests (complete case)
n 1,886 456 
Male sex (%) 52 50 
Caucasian (%) 92 99 
Age (years) 38.6 (26.2; 58.3) 36.8 (26.5; 55.3) 
Duration of diabetes (years) 20.5 (9.7; 39.1) 19.5 (9.4; 33.7) 
A1C (% of hemoglobin) 8.34 (6.4; 11.3) 8.2 (6.4; 10.9) 
Systolic blood pressure (mmHg) 121.1 ± 18.6 117 ± 16.4 
Diastolic blood pressure (mmHg) 74 ± 11.9 74 ± 10.7 
Weight (kg)   
    Men 75.9 ± 10.7 74.5 ± 8.9 
    Women 64.7 ± 10.8 63.2 ± 10.3 
Height (cm)   
    Men 174.8 ± 7.5 174 ± 7.4 
    Women 162.6 ± 7.1 162.8 ± 7.0 
Total cholesterol (mmol/l) 5.33 ± 1.19 5.24 ± 1.1 
Triglycerides (mmol/l) 0.99 (0.52; 2.66) 0.915 (0.47; 2.21) 
Smoking (ever/current) 707 (38) 145 (31) 
Alcohol (>10 units/week) 471 (28) 99 (25) 
CVD 211 (11) 35 (8) 
Microalbuminuria (20–200 μg/min) 306 (18) 62 (15) 
Macroalbuminuria (> 200 μg/min) 216 (9) 11 (3) 
Nonproliferative retinopathy 817 (53) 205 (52) 
Proliferative retinopathy 305 (20) 47 (12) 
Neuropathy 667 (35) 107 (23) 
EURODIAB follow-upNerve conduction tests (complete case)
n 1,886 456 
Male sex (%) 52 50 
Caucasian (%) 92 99 
Age (years) 38.6 (26.2; 58.3) 36.8 (26.5; 55.3) 
Duration of diabetes (years) 20.5 (9.7; 39.1) 19.5 (9.4; 33.7) 
A1C (% of hemoglobin) 8.34 (6.4; 11.3) 8.2 (6.4; 10.9) 
Systolic blood pressure (mmHg) 121.1 ± 18.6 117 ± 16.4 
Diastolic blood pressure (mmHg) 74 ± 11.9 74 ± 10.7 
Weight (kg)   
    Men 75.9 ± 10.7 74.5 ± 8.9 
    Women 64.7 ± 10.8 63.2 ± 10.3 
Height (cm)   
    Men 174.8 ± 7.5 174 ± 7.4 
    Women 162.6 ± 7.1 162.8 ± 7.0 
Total cholesterol (mmol/l) 5.33 ± 1.19 5.24 ± 1.1 
Triglycerides (mmol/l) 0.99 (0.52; 2.66) 0.915 (0.47; 2.21) 
Smoking (ever/current) 707 (38) 145 (31) 
Alcohol (>10 units/week) 471 (28) 99 (25) 
CVD 211 (11) 35 (8) 
Microalbuminuria (20–200 μg/min) 306 (18) 62 (15) 
Macroalbuminuria (> 200 μg/min) 216 (9) 11 (3) 
Nonproliferative retinopathy 817 (53) 205 (52) 
Proliferative retinopathy 305 (20) 47 (12) 
Neuropathy 667 (35) 107 (23) 

Data are means ± SD, skewed distribution: median (5th; 95th percentile), or n (%) unless otherwise indicated.

Close Modal

or Create an Account

Close Modal
Close Modal